Neuro-Oncologists are medical experts who specialize in treating tumors of the brain, spinal cord, and nervous system. Their focus includes both primary brain cancers, such as glioblastoma and astrocytoma, and secondary cancers that have metastasized to the central nervous system. Given the complexity and sensitivity of the nervous system, neuro-oncologists require advanced training in both oncology and neurology. They work closely with multidisciplinary teams—including neurosurgeons, radiation therapists, neurologists, and rehabilitation specialists—to create individualized treatment plans. These may involve surgery, chemotherapy, radiation therapy, or newer approaches like targeted and immunotherapy, all carefully designed to preserve neurological function.
Neuro-oncologists play a critical role in symptom management and long-term care. Brain and spinal tumors often affect speech, movement, memory, or personality, making emotional and cognitive support just as important as physical treatment. Neuro-oncologists monitor patients over time, adjusting therapies and managing side effects such as seizures, swelling, or fatigue. They also support families through the difficult decisions and challenges that come with these diagnoses. Through their specialized care and compassionate approach, neuro-oncologists help patients navigate one of the most complex areas of cancer medicine—striving not only to extend life but also to maintain dignity, function, and quality of life. Their work brings hope to patients facing some of the most daunting and life-altering diagnoses in oncology.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China